News

insider.si.edu

Busher's Automatic Needle Injector

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Herbert Busher, a physician in St ...
Yahoo Finance

EYLEA HD® (aflibercept) Injection 8 mg Applications for Expanded U.S. Label and Prefilled Syringe Receive FDA Review Period Extension

TARRYTOWN, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has extended the target action dates ...
Seeking Alpha

EYLEA HD® (aflibercept) Injection 8 mg Applications for Expanded U.S. Label and Prefilled Syringe Receive FDA Review Period Extension

TARRYTOWN, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (REGN) today announced that the U.S. Food and Drug Administration (FDA) has extended the target action dates to the ...
Pharm Exec

Regeneron Announces FDA Extension for Eylea HD 8mg Injection’s Expanded U.S. Label and Prefilled Syringe Applications

FDA extended review dates for Eylea HD submissions to Q4 2025 due to third-party manufacturing inspection findings. The extension includes a CMC Prior-Approval Supplement for a prefilled syringe and ...
Finanznachrichten

Regeneron Pharmaceuticals, Inc.: EYLEA HD (aflibercept) Injection 8 mg Applications for Expanded U.S. Label and Prefilled Syringe Receive FDA Review Period Extension

TARRYTOWN, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has extended the target action dates ...
Pharm Exec

XOMA Royalty Subsidiary to Acquire Mural Oncology in Premium Cash Transaction

Mural Oncology will be acquired by XRA 5 Corp. for $2.035 per share, with potential additional payments, totaling approximately $36.2 million. The acquisition is part of XOMA's strategy to expand its ...
Healthline

Ozempic: Overview, How It Works, and More

Ozempic is approved by the Food and Drug Administration (FDA) for certain uses in people with type 2 diabetes. It can be prescribed off-label to help with weight loss, but it’s not approved for this ...